|23.12||-0.4800||-2.03%||Vol 216.50K||1Y Perf 113.80%|
|Apr 19th, 2021 15:29 DELAYED|
|- -%||- -|
|Target Price||27.71||Analyst Rating||Strong Buy 1.00|
|Potential %||19.29||Finscreener Ranking||★★★★+ 57.84|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★★★+ 54.45|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★ 52.06|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||— -|
|Market Cap||1.49B||Earnings Rating||Sell|
|Price Range Ratio 52W %||66.60||Earnings Date||6th May 2021|
Today's Price Range
5 Year PE Ratio Range
|Moving Averages:||Strong Buy|
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||6th May 2021|
|Estimated EPS Next Report||-0.20|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||338.02K|
|Avg. Monthly Volume||633.93K|
|Avg. Quarterly Volume||700.00K|
Codexis Inc. (NASDAQ: CDXS) stock closed at 23.6 per share at the end of the most recent trading day (a -3.87% change compared to the prior day closing price) with a volume of 330.39K shares and market capitalization of 1.49B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 161 people. Codexis Inc. CEO is John J. Nicols.
The one-year performance of Codexis Inc. stock is 113.8%, while year-to-date (YTD) performance is 8.11%. CDXS stock has a five-year performance of 532.71%. Its 52-week range is between 10.28 and 29.56, which gives CDXS stock a 52-week price range ratio of 66.60%
Codexis Inc. currently has a PE ratio of -61.60, a price-to-book (PB) ratio of 9.32, a price-to-sale (PS) ratio of 27.79, a price to cashflow ratio of 1 242.70, a PEG ratio of 2.32, a ROA of -12.51%, a ROC of -17.32% and a ROE of -16.85%. The company’s profit margin is -29.41%, its EBITDA margin is -28.00%, and its revenue ttm is $54.39 Million , which makes it $0.84 revenue per share.
Of the last four earnings reports from Codexis Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.20 for the next earnings report. Codexis Inc.’s next earnings report date is 06th May 2021.
The consensus rating of Wall Street analysts for Codexis Inc. is Strong Buy (1), with a target price of $27.71, which is +19.29% compared to the current price. The earnings rating for Codexis Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Codexis Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Codexis Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 20.70, ATR14 : 1.72, CCI20 : 36.90, Chaikin Money Flow : 0.10, MACD : -0.31, Money Flow Index : 69.91, ROC : 12.06, RSI : 38.95, STOCH (14,3) : 65.40, STOCH RSI : 0.72, UO : 46.24, Williams %R : -34.60), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Codexis Inc. in the last 12-months were: Bernard J. Kelley (Option Excercise at a value of $210 200), Bernard J. Kelley (Sold 30 000 shares of value $530 211 ), Bernard Kelley (Sold 15 000 shares of value $214 276 ), Byron Dorgan (Option Excercise at a value of $1 063 000), Byron Dorgan (Sold 100 000 shares of value $1 973 695 ), Dennis P. Wolf (Sold 50 000 shares of value $740 458 ), Thomas R. Baruch (Sold 9 894 shares of value $104 929 )
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.